Mosaic ImmunoEngineering, Inc. is a development-stage biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its pipelines include human and veterinary immuno-oncology programs. The company was founded by Steven King, Paul Lytle, Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, and Robert Garnick on August 21, 2020 and is headquartered in Huntington Beach, CA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company